Image

A Prospective Study on Clinical Effectiveness After SMILE Versus SMILE Xtra in Myopia

A Prospective Study on Clinical Effectiveness After SMILE Versus SMILE Xtra in Myopia

Recruiting
18-50 years
All
Phase N/A

Powered by AI

Overview

To evaluate the clinical efficacy and refractive stability of SMILE Xtra compared to SMILE in patients with myopia

Eligibility

Inclusion Criteria:

  1. Age between 18 and 50 years.
  2. High myopia with a manifest refraction spherical equivalent (MRSE) - 6.00D~-10.00D and refractive changes within ± 0.50D in the past two years;
  3. Best corrected distance visual acuity (CDVA) ≥ 20/25.
  4. Preoperative refractive status is stable (myopia progression not exceeding 0.50D per year for at least 2 years).
  5. Predicted residual stromal thickness (RST) ≥ 250μm after lenticule removal. 6.Soft contact lenses discontinued for at least 1 week, rigid contact lenses for at least 3 weeks, and orthokeratology lenses for at least 3 months.

Exclusion Criteria:

  1. The presence of other eye diseases: keratoconus or suspected keratoconus, active keratoconjunctivitis, severe dry eye, glaucoma, retinal diseases such as retinal tears or macular degeneration, etc.,
  2. The presence of significant corneal scarring or cataracts affects observation.
  3. Systemic diseases such as active systemic inflammation, connective tissue diseases, other conditions that prevent

Study details
    Myopia

NCT06973278

Shanghai Zhongshan Hospital

24 May 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.